Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model
- PMID: 16362942
- DOI: 10.1002/ajim.20246
Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model
Abstract
Background: Japanese consumption of asbestos increased rapidly after the 1950s and lingered at a high level while the world's consumption decreased substantially after the 1980s. Mesothelioma is due primarily to asbestos, and the number of deaths in Japan is expected to increase in the future.
Method: We estimated the future number of pleural mesothelioma deaths among males in Japan using an age-cohort model.
Results: Analyses showed that there would be about 100,000 deaths in Japan due to pleural mesothelioma in the next 40 years. Compared with the statistics in European countries, the ratio of expected death numbers to the population size is remarkably close to linear. The data-point for Japan was slightly lower than that which could be expected from the linear relationship.
Conclusions: The limited availability of data may result in underestimation. Taking into consideration the consumption pattern of asbestos in recent decades, the incorporation of later cohorts will improve the estimation.
Am. J. Ind. Med. 49:1-7, 2006. (c) 2005 Wiley-Liss, Inc.
Similar articles
-
[Relationship between asbestos exposure and malignant pleural mesothelioma: occurrence near the old Japanese naval shipyard].Nihon Kyobu Shikkan Gakkai Zasshi. 1994 Dec;32 Suppl:250-6. Nihon Kyobu Shikkan Gakkai Zasshi. 1994. PMID: 7602840 Japanese.
-
Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia.Occup Environ Med. 2009 Mar;66(3):169-74. doi: 10.1136/oem.2007.038315. Epub 2008 Sep 19. Occup Environ Med. 2009. PMID: 18805882
-
The European mesothelioma epidemic.Br J Cancer. 1999 Feb;79(3-4):666-72. doi: 10.1038/sj.bjc.6690105. Br J Cancer. 1999. PMID: 10027347 Free PMC article.
-
Descriptive epidemiology of malignant mesothelioma.Med Lav. 2005 Jul-Aug;96(4):287-303. Med Lav. 2005. PMID: 16457426 Review.
-
Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005.Crit Rev Toxicol. 2009;39(7):576-88. doi: 10.1080/10408440903044928. Crit Rev Toxicol. 2009. PMID: 19650718 Review.
Cited by
-
Towards elimination of asbestos-related diseases: a theoretical basis for international cooperation.Saf Health Work. 2010 Dec;1(2):103-6. doi: 10.5491/SHAW.2010.1.2.103. Epub 2010 Dec 30. Saf Health Work. 2010. PMID: 22953169 Free PMC article.
-
The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.Cancer Chemother Pharmacol. 2011 Aug;68(2):497-504. doi: 10.1007/s00280-010-1503-x. Epub 2010 Nov 16. Cancer Chemother Pharmacol. 2011. PMID: 21079960 Free PMC article.
-
Awareness of Asbestos and Action Plans for Its Exposure can Help Lives Exposed to Asbestos.Saf Health Work. 2013 Jun;4(2):84-6. doi: 10.1016/j.shaw.2013.04.005. Epub 2013 Apr 18. Saf Health Work. 2013. PMID: 23961330 Free PMC article.
-
Anticancer agent α-sulfoquinovosyl-acylpropanediol enhances the radiosensitivity of human malignant mesothelioma in nude mouse models.J Radiat Res. 2022 Jan 20;63(1):19-29. doi: 10.1093/jrr/rrab090. J Radiat Res. 2022. PMID: 34738103 Free PMC article.
-
Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use.Int J Environ Res Public Health. 2020 Jan 17;17(2):607. doi: 10.3390/ijerph17020607. Int J Environ Res Public Health. 2020. PMID: 31963601 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical